Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Mendelian Randomization and mediation analysis of leukocyte telomere length and risk of lung and head and neck cancers

L. Kachuri, O. Saarela, SE. Bojesen, G. Davey Smith, G. Liu, MT. Landi, NE. Caporaso, DC. Christiani, M. Johansson, S. Panico, K. Overvad, A. Trichopoulou, P. Vineis, G. Scelo, D. Zaridze, X. Wu, D. Albanes, B. Diergaarde, P. Lagiou, GJ....

. 2019 ; 48 (3) : 751-766. [pub] 20190601

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem, Research Support, U.S. Gov't, Non-P.H.S.

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023901

Grantová podpora
U01 CA063673 NCI NIH HHS - United States
U01 CA167462 NCI NIH HHS - United States
P50 CA119997 NCI NIH HHS - United States
UL1 TR000117 NCATS NIH HHS - United States
P50 CA097190 NCI NIH HHS - United States
RP-PG-0707-10034 Department of Health - United Kingdom
R01 CA111703 NCI NIH HHS - United States
G0902313 Medical Research Council - United Kingdom
GSD-137441 CIHR - Canada
UL1 TR000445 NCATS NIH HHS - United States
R35 CA197449 NCI NIH HHS - United States
P30 ES010126 NIEHS NIH HHS - United States
MC_UU_00011/1 Medical Research Council - United Kingdom
K07 CA172294 NCI NIH HHS - United States
P30 CA047904 NCI NIH HHS - United States
C18281/A19169 Cancer Research UK - United Kingdom
P20 RR018787 NCRR NIH HHS - United States
R01 CA151989 NCI NIH HHS - United States
U19 CA148127 NCI NIH HHS - United States
UM1 CA167462 NCI NIH HHS - United States
P30 CA177558 NCI NIH HHS - United States

BACKGROUND: Evidence from observational studies of telomere length (TL) has been conflicting regarding its direction of association with cancer risk. We investigated the causal relevance of TL for lung and head and neck cancers using Mendelian Randomization (MR) and mediation analyses. METHODS: We developed a novel genetic instrument for TL in chromosome 5p15.33, using variants identified through deep-sequencing, that were genotyped in 2051 cancer-free subjects. Next, we conducted an MR analysis of lung (16 396 cases, 13 013 controls) and head and neck cancer (4415 cases, 5013 controls) using eight genetic instruments for TL. Lastly, the 5p15.33 instrument and distinct 5p15.33 lung cancer risk loci were evaluated using two-sample mediation analysis, to quantify their direct and indirect, telomere-mediated, effects. RESULTS: The multi-allelic 5p15.33 instrument explained 1.49-2.00% of TL variation in our data (p = 2.6 × 10-9). The MR analysis estimated that a 1000 base-pair increase in TL increases risk of lung cancer [odds ratio (OR) = 1.41, 95% confidence interval (CI): 1.20-1.65] and lung adenocarcinoma (OR = 1.92, 95% CI: 1.51-2.22), but not squamous lung carcinoma (OR = 1.04, 95% CI: 0.83-1.29) or head and neck cancers (OR = 0.90, 95% CI: 0.70-1.05). Mediation analysis of the 5p15.33 instrument indicated an absence of direct effects on lung cancer risk (OR = 1.00, 95% CI: 0.95-1.04). Analysis of distinct 5p15.33 susceptibility variants estimated that TL mediates up to 40% of the observed associations with lung cancer risk. CONCLUSIONS: Our findings support a causal role for long telomeres in lung cancer aetiology, particularly for adenocarcinoma, and demonstrate that telomere maintenance partially mediates the lung cancer susceptibility conferred by 5p15.33 loci.

BC Cancer Agency Vancouver BC Canada

Clalit National Cancer Control Center at Carmel Medical Center and Technion Faculty of Medicine Haifa Israel

College of Pharmacy Washington State University Spokane WA USA

Departamento de Medicina Preventiva Faculdade de Medicina da Universidade de São Paulo São Paulo Brazil

Department of Cancer Epidemiology and Prevention Cancer Center Maria Sklodowska Curie Institute of Oncology Warsaw Poland

Department of Cancer Epidemiology H Lee Moffitt Cancer Center and Research Institute Tampa FL USA

Department of Clinical Biochemistry Herlev and Gentofte Hospital Copenhagen University Hospital Herlev Ringvej 75 Herlev Denmark Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark

Department of Environmental Epidemiology Nofer Institute of Occupational Medicine Lodz Poland

Department of Epidemiology and Prevention Russian N N Blokhin Cancer Research Centre Moscow Russian Federation

Department of Epidemiology Division of Cancer Prevention and Population Sciences The University of Texas MD Anderson Cancer Center Houston TX USA

Department of Epidemiology Geisel School of Medicine Dartmouth College Hanover NH USA

Department of Epidemiology Gillings School of Global Public Health University of North Carolina at Chapel Hill Chapel Hill NC USA

Department of Gastroenterology Radboud University Nijmegen Medical Center Nijmegen The Netherlands

Department of Genetic Epidemiology University Medical Center Georg August University Göttingen Germany

Department of Human Genetics Graduate School of Public Health University of Pittsburgh Pittsburgh PA USA

Department of Hygiene Epidemiology and Medical Statistics School of Medicine National and Kapodistrian University of Athens Athens Greece

Department of Molecular Biology School of Medicine of São José do Rio Preto São José do Rio Preto Brazil

Department of Oral Pathology School of Dentistry University of São Paulo São Paulo Brazil

Department of Otolaryngology Head and Neck Surgery University of North Carolina at Chapel Hill Chapel Hill NC USA

Department of Otorhinolaryngology Head and Neck Surgery Maastricht University Medical Center Maastricht The Netherlands

Department of Population Health Sciences Huntsman Cancer Institute Salt Lake City UT USA

Department of Public Health Section for Epidemiology Aarhus University Aarhus Denmark

Department of Thoracic Surgery and Division of Epidemiology Vanderbilt University Medical Center Nashville TN USA

Department of Thoracopulmonary Pathology Service of Pathology Clinical Center of Serbia Belgrade Serbia

Departments of Epidemiology and Environmental Health Harvard TH Chan School of Public Health Boston MA USA Department of Medicine Massachusetts General Hospital and Harvard Medical School Boston MA USA

Dipartimento di Medicina Clinica e Chirurgia Federico 2 University Naples Italy

Division of Biostatistics Dalla Lana School of Public Health University of Toronto Toronto Ontario Canada

Division of Cancer Epidemiology and Genetics National Cancer Institute National Institutes of Health Bethesda MD USA

Division of Epidemiology Dalla Lana School of Public Health University of Toronto Toronto Ontario Canada Ontario Cancer Institute Princess Margaret Cancer Center Toronto Ontario Canada

Division of Epigenomics and Cancer Risk Factors German Cancer Research Center Heidelberg Germany

Epidemiology Program University of Hawaii Cancer Center Honolulu HI USA

Faculdade de Saúde Pública Universidade de São Paulo Brazil

Faculty of Health Sciences Palacky University Olomouc Czech Republic

Faculty of Medicine University of Oviedo and CIBERESP Campus del Cristo Oviedo Spain

Fondazione Policlinico Universitario A Gemelli IRCCS Rome Italia Section of Hygiene Institute of Public Health Università Cattolica del Sacro Cuore Rome Italy

Fred Hutchinson Cancer Research Center Seattle WA USA

Hellenic Health Foundation and WHO Collaborating Center for Nutrition and Health Unit of Nutritional Epidemiology and Nutrition in Public Health Athens Greece Department of Hygiene Epidemiology and Medical Statistics School of Medicine National and Kapodistrian University of Athens Athens Greece

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Disciplina de Cirurgia de Cabeça e Pescoço São Paulo Brasil

Institute for Clinical and Translational Research Baylor College of Medicine Houston TX USA

Institute of Epidemiology 2 Helmholtz Zentrum München German Research Center for Environmental Health Neuherberg Germany Institute of Medical Informatics Biometry and Epidemiology Ludwig Maximilians University Munich Germany Institute of Medical Statistics and Epidemiology Technical University Munich Germany

Institute of Public Health and Preventive Medicine 2nd Faculty of Medicine Charles University Prague Czech Republic

International Agency for Research on Cancer Lyon France

International Agency for Research on Cancer Lyon France Icahn School of Medicine at Mount Sinai New York NY USA

Lunenfeld Tanenbaum Research Institute Sinai Health System Toronto Ontario Canada

Lunenfeld Tanenbaum Research Institute Sinai Health System Toronto Ontario Canada Division of Epidemiology Dalla Lana School of Public Health University of Toronto Toronto Ontario Canada

Markey Cancer Center University of Kentucky Lexington KY USA

MRC PHE Centre for Environment and Health Department of Epidemiology and Biostatistics School of Public Health Imperial College London London UK

National Institute of Public Health Bucharest Romania

Population Health Science Bristol Medical School MRC Integrative Epidemiology Unit University of Bristol Bristol UK

Radboud Institute for Health Sciences Radboud University Medical Centre Nijmegen The Netherlands

Roy Castle Lung Cancer Research Programme University of Liverpool Cancer Research Centre Institute of Translational Medicine University of Liverpool Liverpool UK

School of Health and Related Research University of Sheffield Sheffield UK

School of Oral and Dental Sciences University of Bristol Bristol UK

Skåne University Hospital Lund University Lund Sweden

The Institute of Applied Health Sciences School of Medicine University of Aberdeen Aberdeen UK

The National Institute of Occupational Health Oslo Norway

Unit of Nutrition and Cancer Catalan Institute of Oncology Barcelona Spain

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023901
003      
CZ-PrNML
005      
20201214131627.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/ije/dyy140 $2 doi
035    __
$a (PubMed)30059977
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Kachuri, Linda $u Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada. Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
245    10
$a Mendelian Randomization and mediation analysis of leukocyte telomere length and risk of lung and head and neck cancers / $c L. Kachuri, O. Saarela, SE. Bojesen, G. Davey Smith, G. Liu, MT. Landi, NE. Caporaso, DC. Christiani, M. Johansson, S. Panico, K. Overvad, A. Trichopoulou, P. Vineis, G. Scelo, D. Zaridze, X. Wu, D. Albanes, B. Diergaarde, P. Lagiou, GJ. Macfarlane, MC. Aldrich, A. Tardón, G. Rennert, AF. Olshan, MC. Weissler, C. Chen, GE. Goodman, JA. Doherty, AR. Ness, H. Bickeböller, HE. Wichmann, A. Risch, JK. Field, MD. Teare, LA. Kiemeney, EHFM. van der Heijden, JC. Carroll, A. Haugen, S. Zienolddiny, V. Skaug, V. Wünsch-Filho, EH. Tajara, R. Ayoub Moysés, F. Daumas Nunes, S. Lam, J. Eluf-Neto, M. Lacko, WHM. Peters, L. Le Marchand, EJ. Duell, AS. Andrew, S. Franceschi, MB. Schabath, J. Manjer, S. Arnold, P. Lazarus, A. Mukeriya, B. Swiatkowska, V. Janout, I. Holcatova, J. Stojsic, D. Mates, J. Lissowska, S. Boccia, C. Lesseur, X. Zong, JD. McKay, P. Brennan, CI. Amos, RJ. Hung,
520    9_
$a BACKGROUND: Evidence from observational studies of telomere length (TL) has been conflicting regarding its direction of association with cancer risk. We investigated the causal relevance of TL for lung and head and neck cancers using Mendelian Randomization (MR) and mediation analyses. METHODS: We developed a novel genetic instrument for TL in chromosome 5p15.33, using variants identified through deep-sequencing, that were genotyped in 2051 cancer-free subjects. Next, we conducted an MR analysis of lung (16 396 cases, 13 013 controls) and head and neck cancer (4415 cases, 5013 controls) using eight genetic instruments for TL. Lastly, the 5p15.33 instrument and distinct 5p15.33 lung cancer risk loci were evaluated using two-sample mediation analysis, to quantify their direct and indirect, telomere-mediated, effects. RESULTS: The multi-allelic 5p15.33 instrument explained 1.49-2.00% of TL variation in our data (p = 2.6 × 10-9). The MR analysis estimated that a 1000 base-pair increase in TL increases risk of lung cancer [odds ratio (OR) = 1.41, 95% confidence interval (CI): 1.20-1.65] and lung adenocarcinoma (OR = 1.92, 95% CI: 1.51-2.22), but not squamous lung carcinoma (OR = 1.04, 95% CI: 0.83-1.29) or head and neck cancers (OR = 0.90, 95% CI: 0.70-1.05). Mediation analysis of the 5p15.33 instrument indicated an absence of direct effects on lung cancer risk (OR = 1.00, 95% CI: 0.95-1.04). Analysis of distinct 5p15.33 susceptibility variants estimated that TL mediates up to 40% of the observed associations with lung cancer risk. CONCLUSIONS: Our findings support a causal role for long telomeres in lung cancer aetiology, particularly for adenocarcinoma, and demonstrate that telomere maintenance partially mediates the lung cancer susceptibility conferred by 5p15.33 loci.
650    _2
$a adenokarcinom plic $x epidemiologie $7 D000077192
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a spinocelulární karcinom $x epidemiologie $7 D002294
650    _2
$a lidské chromozomy, pár 5 $x genetika $7 D002895
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a nádory hlavy a krku $x epidemiologie $7 D006258
650    _2
$a lidé $7 D006801
650    _2
$a leukocyty $x metabolismus $7 D007962
650    _2
$a nádory plic $x epidemiologie $7 D008175
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mendelovská randomizace $7 D057182
650    _2
$a lidé středního věku $7 D008875
650    _2
$a dlaždicobuněčné karcinomy hlavy a krku $x epidemiologie $7 D000077195
650    _2
$a telomery $x metabolismus $7 D016615
650    _2
$a homeostáza telomer $x genetika $7 D059505
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486
700    1_
$a Saarela, Olli $u Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
700    1_
$a Bojesen, Stig Egil $u Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, Herlev, Denmark. Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
700    1_
$a Davey Smith, George $u Population Health Science, Bristol Medical School, MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
700    1_
$a Liu, Geoffrey $u Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. Ontario Cancer Institute, Princess Margaret Cancer Center, Toronto, Ontario, Canada.
700    1_
$a Landi, Maria Teresa $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
700    1_
$a Caporaso, Neil E $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
700    1_
$a Christiani, David C $u Departments of Epidemiology and Environmental Health, Harvard TH Chan School of Public Health, Boston, MA, USA. Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
700    1_
$a Johansson, Mattias $u International Agency for Research on Cancer, Lyon, France.
700    1_
$a Panico, Salvatore $u Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
700    1_
$a Overvad, Kim $u Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.
700    1_
$a Trichopoulou, Antonia $u Hellenic Health Foundation, and WHO Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Athens, Greece. Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
700    1_
$a Vineis, Paolo $u MRC/PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
700    1_
$a Scelo, Ghislaine $u International Agency for Research on Cancer, Lyon, France.
700    1_
$a Zaridze, David $u Department of Epidemiology and Prevention, Russian N.N.Blokhin Cancer Research Centre, Moscow, Russian Federation.
700    1_
$a Wu, Xifeng $u Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
700    1_
$a Albanes, Demetrius $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
700    1_
$a Diergaarde, Brenda $u Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
700    1_
$a Lagiou, Pagona $u Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
700    1_
$a Macfarlane, Gary J $u The Institute of Applied Health Sciences, School of Medicine, University of Aberdeen, Aberdeen, UK.
700    1_
$a Aldrich, Melinda C $u Department of Thoracic Surgery and Division of Epidemiology, Vanderbilt University Medical Center, Nashville, TN, USA.
700    1_
$a Tardón, Adonina $u Faculty of Medicine, University of Oviedo and CIBERESP, Campus del Cristo, Oviedo, Spain.
700    1_
$a Rennert, Gad $u Clalit National Cancer Control Center at Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
700    1_
$a Olshan, Andrew F $u Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
700    1_
$a Weissler, Mark C $u Department of Otolaryngology/Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
700    1_
$a Chen, Chu $u Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
700    1_
$a Goodman, Gary E $u Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
700    1_
$a Doherty, Jennifer A $u Department of Population Health Sciences, Huntsman Cancer Institute, Salt Lake City, UT, USA.
700    1_
$a Ness, Andrew R $u School of Oral and Dental Sciences, University of Bristol, Bristol, UK.
700    1_
$a Bickeböller, Heike $u Department of Genetic Epidemiology, University Medical Center, Georg-August-University, Göttingen, Germany.
700    1_
$a Wichmann, H-Erich $u Institute of Epidemiology II, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany. Institute of Medical Informatics, Biometry and Epidemiology, Ludwig Maximilians University, Munich, Germany. Institute of Medical Statistics and Epidemiology, Technical University, Munich, Germany.
700    1_
$a Risch, Angela $u Division of Epigenomics & Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany.
700    1_
$a Field, John K $u Roy Castle Lung Cancer Research Programme, University of Liverpool Cancer Research Centre Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
700    1_
$a Teare, M Dawn $u School of Health and Related Research, University of Sheffield, Sheffield, UK.
700    1_
$a Kiemeney, Lambertus A $u Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.
700    1_
$a van der Heijden, Erik H F M $u Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.
700    1_
$a Carroll, June C $u Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
700    1_
$a Haugen, Aage $u The National Institute of Occupational Health, Oslo, Norway.
700    1_
$a Zienolddiny, Shanbeh $u The National Institute of Occupational Health, Oslo, Norway.
700    1_
$a Skaug, Vidar $u The National Institute of Occupational Health, Oslo, Norway.
700    1_
$a Wünsch-Filho, Victor $u Faculdade de Saúde Pública, Universidade de São Paulo, Brazil.
700    1_
$a Tajara, Eloiza H $u Department of Molecular Biology, School of Medicine of São José do Rio Preto, São José do Rio Preto, Brazil.
700    1_
$a Ayoub Moysés, Raquel $u Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Disciplina de Cirurgia de Cabeça e Pescoço (LIM28), São Paulo, Brasil.
700    1_
$a Daumas Nunes, Fabio $u Department of Oral Pathology, School of Dentistry, University of São Paulo, São Paulo, Brazil.
700    1_
$a Lam, Stephen $u BC Cancer Agency, Vancouver, BC, Canada.
700    1_
$a Eluf-Neto, Jose $u Departamento de Medicina Preventiva, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
700    1_
$a Lacko, Martin $u Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, Maastricht, The Netherlands.
700    1_
$a Peters, Wilbert H M $u Department of Gastroenterology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
700    1_
$a Le Marchand, Loïc $u Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
700    1_
$a Duell, Eric J $u Unit of Nutrition and Cancer, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
700    1_
$a Andrew, Angeline S $u Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA.
700    1_
$a Franceschi, Silvia $u International Agency for Research on Cancer, Lyon, France.
700    1_
$a Schabath, Matthew B $u Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
700    1_
$a Manjer, Jonas $u Skåne University Hospital, Lund University, Lund, Sweden.
700    1_
$a Arnold, Susanne $u Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
700    1_
$a Lazarus, Philip $u College of Pharmacy, Washington State University, Spokane, WA, USA.
700    1_
$a Mukeriya, Anush $u Department of Epidemiology and Prevention, Russian N.N.Blokhin Cancer Research Centre, Moscow, Russian Federation.
700    1_
$a Swiatkowska, Beata $u Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Lodz, Poland.
700    1_
$a Janout, Vladimir $u Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic.
700    1_
$a Holcatova, Ivana $u Institute of Public Health and Preventive Medicine, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Stojsic, Jelena $u Department of Thoracopulmonary Pathology, Service of Pathology, Clinical Center of Serbia, Belgrade, Serbia.
700    1_
$a Mates, Dana $u National Institute of Public Health, Bucharest, Romania.
700    1_
$a Lissowska, Jolanta $u Department of Cancer Epidemiology and Prevention, Cancer Center Maria Sklodowska-Curie Institute of Oncology, Warsaw, Poland.
700    1_
$a Boccia, Stefania $u Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italia. Section of Hygiene, Institute of Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
700    1_
$a Lesseur, Corina $u International Agency for Research on Cancer, Lyon, France. Icahn School of Medicine at Mount Sinai, New York, NY, USA.
700    1_
$a Zong, Xuchen $u Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
700    1_
$a McKay, James D $u International Agency for Research on Cancer, Lyon, France.
700    1_
$a Brennan, Paul $u International Agency for Research on Cancer, Lyon, France.
700    1_
$a Amos, Christopher I $u Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA.
700    1_
$a Hung, Rayjean J $u Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada. Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
773    0_
$w MED00002316 $t International journal of epidemiology $x 1464-3685 $g Roč. 48, č. 3 (2019), s. 751-766
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30059977 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214131622 $b ABA008
999    __
$a ok $b bmc $g 1596220 $s 1114577
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 48 $c 3 $d 751-766 $e 20190601 $i 1464-3685 $m International journal of epidemiology $n Int J Epidemiol $x MED00002316
GRA    __
$a U01 CA063673 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA167462 $p NCI NIH HHS $2 United States
GRA    __
$a P50 CA119997 $p NCI NIH HHS $2 United States
GRA    __
$a UL1 TR000117 $p NCATS NIH HHS $2 United States
GRA    __
$a P50 CA097190 $p NCI NIH HHS $2 United States
GRA    __
$a RP-PG-0707-10034 $p Department of Health $2 United Kingdom
GRA    __
$a R01 CA111703 $p NCI NIH HHS $2 United States
GRA    __
$a G0902313 $p Medical Research Council $2 United Kingdom
GRA    __
$a GSD-137441 $p CIHR $2 Canada
GRA    __
$a UL1 TR000445 $p NCATS NIH HHS $2 United States
GRA    __
$a R35 CA197449 $p NCI NIH HHS $2 United States
GRA    __
$a P30 ES010126 $p NIEHS NIH HHS $2 United States
GRA    __
$a MC_UU_00011/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a K07 CA172294 $p NCI NIH HHS $2 United States
GRA    __
$a P30 CA047904 $p NCI NIH HHS $2 United States
GRA    __
$a C18281/A19169 $p Cancer Research UK $2 United Kingdom
GRA    __
$a P20 RR018787 $p NCRR NIH HHS $2 United States
GRA    __
$a R01 CA151989 $p NCI NIH HHS $2 United States
GRA    __
$a U19 CA148127 $p NCI NIH HHS $2 United States
GRA    __
$a UM1 CA167462 $p NCI NIH HHS $2 United States
GRA    __
$a P30 CA177558 $p NCI NIH HHS $2 United States
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace